Literature DB >> 15890517

Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts.

Akira Sawa1, Eiichiro Nagata, Siobhan Sutcliffe, Pratima Dulloor, Matthew B Cascio, Yuji Ozeki, Sophie Roy, Christopher A Ross, Solomon H Snyder.   

Abstract

Accumulation of mutant Huntingtin (Htt), especially the N-terminal-cleaved Htt, participates in the pathophysiology of Huntington's disease (HD). It is difficult to elucidate temporal properties of the translocation of "endogenous" Htt using autopsy HD patient brains. Thus, we examined the cell biology of "endogenous" Htt cleavage and nuclear translocation in cultured lymphoblasts of HD patients and controls. Apoptotic stimulation of lymphoblasts elicits caspase-dependent cleavage and selective nuclear translocation of N-terminal portions of Htt. Discrete clusters of the N-terminal Htt accumulate at unique perinuclear sites prior to nuclear translocation. Our findings suggest that caspase cleavage of Htt is cytoplasmic and precedes sorting to specific perinuclear sites followed by nuclear translocation in HD patient tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890517     DOI: 10.1016/j.nbd.2005.02.013

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  20 in total

1.  Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease.

Authors:  Kuan-Yu Liu; Yu-Chiau Shyu; Brett A Barbaro; Yuan-Ta Lin; Yijuang Chern; Leslie Michels Thompson; Che-Kun James Shen; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2014-11-14       Impact factor: 6.150

Review 2.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

3.  Structural formation of huntingtin exon 1 aggregates probed by small-angle neutron scattering.

Authors:  Christopher B Stanley; Tatiana Perevozchikova; Valerie Berthelier
Journal:  Biophys J       Date:  2011-05-18       Impact factor: 4.033

4.  Investigating the structural impact of the glutamine repeat in huntingtin assembly.

Authors:  Tatiana Perevozchikova; Christopher B Stanley; Helen P McWilliams-Koeppen; Erica L Rowe; Valerie Berthelier
Journal:  Biophys J       Date:  2014-07-15       Impact factor: 4.033

5.  Prothymosin-α interacts with mutant huntingtin and suppresses its cytotoxicity in cell culture.

Authors:  Gaofeng Dong; Eduardo A Callegari; Christian J Gloeckner; Marius Ueffing; Hongmin Wang
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

6.  Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin.

Authors:  Tamara Ratovitski; Ekaterine Chighladze; Elaine Waldron; Ricky R Hirschhorn; Christopher A Ross
Journal:  J Biol Chem       Date:  2011-02-10       Impact factor: 5.157

7.  Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization.

Authors:  Andreas Vitalis; Xiaoling Wang; Rohit V Pappu
Journal:  J Mol Biol       Date:  2008-09-18       Impact factor: 5.469

8.  Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH.

Authors:  Byoung-Il Bae; Makoto R Hara; Matthew B Cascio; Cheryl L Wellington; Michael R Hayden; Christopher A Ross; Hyo Chol Ha; Xiao-Jiang Li; Solomon H Snyder; Akira Sawa
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

9.  Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells.

Authors:  Tamara Ratovitski; Marjan Gucek; Haibing Jiang; Ekaterine Chighladze; Elaine Waldron; James D'Ambola; Zhipeng Hou; Yideng Liang; Michelle A Poirier; Ricky R Hirschhorn; Rona Graham; Michael R Hayden; Robert N Cole; Christopher A Ross
Journal:  J Biol Chem       Date:  2009-02-09       Impact factor: 5.157

10.  A novel target for Huntington's disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology.

Authors:  László Bodai; J Lawrence Marsh
Journal:  Bioessays       Date:  2012-02       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.